{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-336946","form_type":"8-K","ticker":"IVVD","cik":"0001832038","company_name":"Invivyd, Inc.","filed_at":"2021-11-22T23:59:59+00:00","discovered_at":"2026-05-14T18:04:14.531368+00:00","generated_at":"2026-06-28T06:14:37.247943+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Adagio adds Jill Andersen as CLO, Redonda Miller and Ellen Marram to board","bullets":["Jill Andersen appointed chief legal officer; previously at Oyster Point Pharma and Bristol Myers Squibb.","Dr. Redonda Miller (president of Johns Hopkins Hospital) and Ellen Marram (former CEO of Tropicana/Nabisco) join board.","Appointments aim to support rapid advancement and potential EUA of ADG20 for COVID-19.","Ellen Marram to serve on Nominating and Corporate Governance Committee; Dr. Miller on Compensation Committee."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-336946","json":"https://secwatch.observer/filing/0001193125-21-336946.json","markdown":"https://secwatch.observer/filing/0001193125-21-336946.md","text":"https://secwatch.observer/filing/0001193125-21-336946.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1832038/000119312521336946/0001193125-21-336946-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1832038/000119312521336946/d260621d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T06:14:37.247943+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3c39cb966c","claim":"Ellen Marram was appointed as director at Invivyd, Inc..","evidence_excerpt":"On November 19, 2021, the board of directors (the “Board”) of Adagio Therapeutics, Inc. (the “Company”) appointed Ms. Ellen Marram and Dr. Redonda Miller to serve as directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1832038/000119312521336946/0001193125-21-336946-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"director"}],"fact_type":"executive_change"},{"claim_id":"e8f874d236","claim":"Redonda Miller was appointed as director at Invivyd, Inc..","evidence_excerpt":"On November 19, 2021, the board of directors (the “Board”) of Adagio Therapeutics, Inc. (the “Company”) appointed Ms. Ellen Marram and Dr. Redonda Miller to serve as directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1832038/000119312521336946/0001193125-21-336946-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}